Clinical Trials on Vital Sign in Australia

Total 734 results

Viravaxx AG
Gouya Insights; KKS MedUni Vienna

Recruiting

Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001

Hepatitis B

Austria
GlaxoSmithKline

Completed

Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs

Hepatitis B

Belgium, Ukraine, Australia
Dynavax Technologies Corporation

Completed

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers

Herpes Zoster | Vaccine-Preventable Diseases | Shingles

Australia
Hoffmann-La Roche

Withdrawn

ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.

HIV Infections

Australia
Kirby Institute
Merck Sharp & Dohme LLC

Completed

The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection (PINT)

HIV Infection

Australia
ACM Biolabs

Completed

Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.

SARS-CoV-2 Infection

Australia
Macfarlane Burnet Institute for Medical Research...
The Alfred

Completed

Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals (co-EC)

Hepatitis C | HIV

Australia
Valneva Austria GmbH

Completed

This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population

Japanese Encephalitis

Germany, Austria
Kirby Institute
National Health and Medical Research Council, Australia

Recruiting

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings (ETHOS II)

Hepatitis C

Australia
University of North Carolina, Chapel Hill
National Institute of Mental Health (NIMH); University of Aarhus; University... and other collaborators

Completed

Eating Disorders Genetics Initiative (EDGI)

Anorexia Nervosa | Binge-Eating Disorder | Bulimia Nervosa

United States, Australia, New Zealand
Pfizer

Completed

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

Encephalitis, Tick-borne

Austria
Valneva Austria GmbH

Completed

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

Japanese Encephalitis

Germany, Austria
Kirby Institute
Gilead Sciences; Melanoma Institute Australia; St Vincent's Hospital, Sydney; Royal... and other collaborators

Active, not recruiting

Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) (CORIA)

COVID-19 | Cancer | Primary Immune Deficiency Disorder | HIV-1-infection | Immunosuppression Disorders

Australia
University of Vienna

Recruiting

Evaluation of Inflammatory Cytokines During COVID-19

Covid19

Austria
Medical University of Graz
CBmed Ges.m.b.H.

Active, not recruiting

Post COVID-19 Syndrome and the Gut-lung Axis

Covid19

Austria
University of Vienna
SMZ-Ost Donauspital

Recruiting

DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients (ABCD)

Covid19

Austria
Apeiron Biologics
Apeiron Respiratory Therapies GmbH

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled APN01 Developed as Treatment for COVID-19

Covid19

Austria
Medical University of Vienna

Completed

The Effects of a Multi-factorial Rehabilitation Program for Healthcare Workers Suffering From Post-COVID-19 Fatigue Syndrome

COVID-19

Austria
Medical University of Vienna

Completed

Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders (NRSily)

Hepatitis C

Austria
Medical University Innsbruck

Recruiting

α-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19

COVID-19

Austria
Novavax

Completed

A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine (COVID-19)

COVID-19 | Influenza

Australia, New Zealand
Medical University of Graz

Completed

Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals (CoVVac)

Covid19 | Immunosuppression

Austria
GlaxoSmithKline

Completed

Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B

Hepatitis B

Austria
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine

Hepatitis B

Austria
Ludwig Boltzmann Institute for Lung Health

Completed

CoVid-19 - Infection and Antibody Formation in the Viennese Population

Virus Diseases | COVID-19

Austria
Macfarlane Burnet Institute for Medical Research...
St Vincent's Hospital Melbourne

Completed

The Prime Study - Comparing Hepatitis C Care and Treatment in a Primary Health Care Service With a Tertiary Hospital

Hepatitis C

Australia, New Zealand
Xiyuan Hospital of China Academy of Chinese Medical...

Recruiting

International Clinical Study of Zhizhu Kuanzhong Capsule

Functional Dyspepsia | Postprandial Distress Syndrome

China, Australia
Medical University of Graz

Completed

Quantification of Side Effects During Hepatitis C Therapy

Hepatitis C

Austria
Medical University of Vienna

Recruiting

Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

COVID-19 | Post-COVID-19 Syndrome

Austria
Medical University Innsbruck

Recruiting

Prospective Multidisciplinary Post-COVID-19 Registry Tyrol (PRECISE)

Post COVID-19 Condition

Austria
Medical University of Graz

Active, not recruiting

Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection (SynCov)

COVID

Austria
Medical University of Vienna

Unknown

Vienna Versus SARS-CoV-2 Virus Study (VIVI)

COVID-19 | SARS-CoV-2

Austria
Medical University of Vienna

Completed

Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC) (AURIC)

Cirrhosis | Chronic Hepatitis C

Austria
Melbourne Health
Hoffmann-La Roche; Monash University; The University of New South Wales; St Vincent... and other collaborators

Completed

Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy

Chronic Hepatitis C

Australia
GlaxoSmithKline

Completed

Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B

Hepatitis B

Austria
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia

Dengue Fever | Dengue Hemorrhagic Fever

Australia
GlaxoSmithKline

Terminated

A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons

Herpes Genitalis

United States, Australia, Hong Kong
Alnylam Pharmaceuticals

Terminated

A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection

Hepatitis B | Chronic Hepatitis B | Hepatitis B, Chronic | HBV | Hepatitis B Infection

United Kingdom, New Zealand, Singapore, Korea, Republic of, Australia, Hong Kong
University of Salzburg
Austrian Science Fund (FWF)

Completed

Becoming a Parent During the COVID-19 Pandemic in Austria and Germany

Parents | COVID-19 Pandemic

Austria
Ludwig Boltzmann Institute for Digital Health and...
Institute of Sports Medicine, Prevention and Rehabilitation, Salzburg, Austria

Completed

Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19 (CODIS)

Cardiac Rehabilitation

Austria
Bruce Brew
ViiV Healthcare

Completed

A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac) (HANDmac)

Human Immunodeficiency Virus (HIV) | HIV Associated Neurocognitive Disorders (HAND)

Australia
St. Anna Kinderkrebsforschung

Completed

COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS) (INPOSIS)

Covid19 | SARS-CoV-2 Infection | Intestinal Infection

Austria
BlueSky Immunotherapies GmbH

Completed

Study of FluBHPVE6E7 in HPV-16 Infected Women

HPV Infection

Austria
Hoffmann-La Roche

Completed

An Observational Study of Peginterferon Alfa-2a Plus Ribavirin for Hepatitis C Virus (HCV) Infection in Austria

Hepatitis C

Austria
Andrew Carr
ViiV Healthcare Australia Pty. Ltd

Completed

The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure Prophylaxis (dPEP)

Human Immunodeficiency Virus

Australia
Mucpharm Pty Ltd
St George Hospital, Australia; Mobius Medical Pty Ltd.

Completed

Nebulised BromAc in Healthy Volunteers

COVID-19 Pneumonia | COVID-19 Acute Respiratory Distress Syndrome | Bromelains Adverse Reaction | Acetylcysteine Adverse Reaction | Mucus; Plug

Australia
Medical University Innsbruck
Claudiana Landesfachhochschule

Unknown

Health After Covid-19 in Tyrol

COVID-19

Austria
St Vincent's Hospital, Sydney
Merck Sharp & Dohme LLC

Terminated

A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV (HANDral)

Human Immunodeficiency Virus (HIV) | HIV Associated Neurocognitive Disorders (HAND)

Australia
Marinomed Biotech AG

Completed

Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients

Covid19

Austria
Assembly Biosciences

Completed

Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of, Taiwan, Australia, Hong Kong, United Kingdom

Clinical Trials on Vital Sign in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations